1. Biochemistry and Chemical Biology
  2. Chromosomes and Gene Expression

Hfq CLASH uncovers sRNA-target interaction networks linked to nutrient availability adaptation

  1. Ira Alexandra Iosub
  2. Rob Willem van Nues
  3. Stuart William McKellar
  4. Karen Jule Nieken
  5. Marta Marchioretto
  6. Brandon Sy
  7. Jai J Tree
  8. Gabriella Viero
  9. Sander Granneman  Is a corresponding author
  1. University of Edinburgh, United Kingdom
  2. CNR, Italy
  3. University of New South Wales, Australia
  4. CNR Unit, Italy
https://doi.org/10.7554/eLife.54655
Share this article
Cite this article
  1. Ira Alexandra Iosub
  2. Rob Willem van Nues
  3. Stuart William McKellar
  4. Karen Jule Nieken
  5. Marta Marchioretto
  6. Brandon Sy
  7. Jai J Tree
  8. Gabriella Viero
  9. Sander Granneman
(2020)
Hfq CLASH uncovers sRNA-target interaction networks linked to nutrient availability adaptation
eLife 9:e54655.
https://doi.org/10.7554/eLife.54655
  2. Download BibTeX
  3. Download .RIS

Abstract

By shaping gene expression profiles, small RNAs (sRNAs) enable bacteria to efficiently adapt to changes in their environment. To better understand how Escherichia coli acclimatizes to nutrient availability, we performed UV cross-linking, ligation and sequencing of hybrids (CLASH) to uncover Hfq-associated RNA-RNA interactions at specific growth stages. We demonstrate that Hfq CLASH robustly captures bona fide RNA-RNA interactions identified hundreds of novel sRNA base-pairing interactions, including many sRNA-sRNA interactions and involving 3'UTR-derived sRNAs. We rediscovered known and identified novel sRNA seed sequences. The sRNA-mRNA interactions identified by CLASH have strong base-pairing potential and are highly enriched for complementary sequence motifs, even those supported by only a few reads. Yet, steady state levels of most mRNA targets were not significantly affected upon over-expression of the sRNA regulator. Our results reinforce the idea that the reproducibility of the interaction, not base-pairing potential, is a stronger predictor for a regulatory outcome.

Data availability

The next generation sequencing data have been deposited on the NCBI Gene Expression Omnibus (GEO) with accession number GSE123050. The python pyCRAC (Webb et al., 2014), kinetic-CRAC and GenomeBrowser software packages used for analysing the data are available from https://bitbucket.org/sgrann (pyCRAC up to version 1.4.3), https://git.ecdf.ed.ac.uk/sgrannem/ and pypi (https://pypi.org/user/g_ronimo/). The hyb pipeline for identifying chimeric reads is available from https://github.com/gkudla/hyb. The scripts for statistical analysis of hyb data is available from https://bitbucket.org/jaitree/hyb_stats/. The FLASH algorithm for merging paired reads is available from https://github.com/dstreett/FLASH2. Bedgraph and Gene Transfer Format (GTF) generated from the analysis of the Hfq CLASH, RNA-seq and TEX RNA-seq data (Thomason et al., 2015) are available from the Granneman lab DataShare repository (https://datashare.is.ed.ac.uk/handle/10283/2915).

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Ira Alexandra Iosub

    SynthSys, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2924-2471

  2. Rob Willem van Nues

    ICB, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.

  3. Stuart William McKellar

    IQB3, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0792-9878

  4. Karen Jule Nieken

    Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.

  5. Marta Marchioretto

    Institute of Biophysics, CNR, Trento, Italy
    Competing interests
    The authors declare that no competing interests exist.

  6. Brandon Sy

    School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.

  7. Jai J Tree

    School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.

  8. Gabriella Viero

    Institute of Biophysics, CNR Unit, Trento, Italy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6755-285X

  9. Sander Granneman

    SynthSys, University of Edinburgh, Edinburgh, United Kingdom
    For correspondence
    sgrannem@ed.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4387-1271

Funding

Wellcome (102334)

  • Ira Alexandra Iosub

Wellcome (091549)

  • Sander Granneman

Medical Research Council (MR/R008205/1)

  • Sander Granneman

Australian National Health (GNT1067241)

  • Jai J Tree

Australian Medical Research Council (GNT1139313)

  • Jai J Tree

Axonomix (N/A)

  • Gabriella Viero

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Iosub et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,544
    views
  • 439
    downloads
  • 81
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ira Alexandra Iosub
  2. Rob Willem van Nues
  3. Stuart William McKellar
  4. Karen Jule Nieken
  5. Marta Marchioretto
  6. Brandon Sy
  7. Jai J Tree
  8. Gabriella Viero
  9. Sander Granneman
(2020)
Hfq CLASH uncovers sRNA-target interaction networks linked to nutrient availability adaptation
eLife 9:e54655.
https://doi.org/10.7554/eLife.54655

Share this article

https://doi.org/10.7554/eLife.54655

Categories and tags

Research organism

Further reading

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease

    The nanoscale organization of the Nipah virus fusion protein informs new membrane fusion mechanisms

    Qian Wang, Jinxin Liu ... Qian Liu
    Research Article

    Paramyxovirus membrane fusion requires an attachment protein for receptor binding and a fusion protein for membrane fusion triggering. Nipah virus (NiV) attachment protein (G) binds to ephrinB2 or -B3 receptors, and fusion protein (F) mediates membrane fusion. NiV-F is a class I fusion protein and is activated by endosomal cleavage. The crystal structure of a soluble GCN4-decorated NiV-F shows a hexamer-of-trimer assembly. Here, we used single-molecule localization microscopy to quantify the NiV-F distribution and organization on cell and virus-like particle membranes at a nanometer precision. We found that NiV-F on biological membranes forms distinctive clusters that are independent of endosomal cleavage or expression levels. The sequestration of NiV-F into dense clusters favors membrane fusion triggering. The nano-distribution and organization of NiV-F are susceptible to mutations at the hexamer-of-trimer interface, and the putative oligomerization motif on the transmembrane domain. We also show that NiV-F nanoclusters are maintained by NiV-F–AP-2 interactions and the clathrin coat assembly. We propose that the organization of NiV-F into nanoclusters facilitates membrane fusion triggering by a mixed population of NiV-F molecules with varied degrees of cleavage and opportunities for interacting with the NiV-G/receptor complex. These observations provide insights into the in situ organization and activation mechanisms of the NiV fusion machinery.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics

    Impact of the clinically approved BTK inhibitors on the conformation of full-length BTK and analysis of the development of BTK resistance mutations in chronic lymphocytic leukemia

    Raji E Joseph, Thomas E Wales ... Amy H Andreotti
    Research Advance

    Inhibition of Bruton’s tyrosine kinase (BTK) has proven to be highly effective in the treatment of B-cell malignancies such as chronic lymphocytic leukemia (CLL), autoimmune disorders, and multiple sclerosis. Since the approval of the first BTK inhibitor (BTKi), Ibrutinib, several other inhibitors including Acalabrutinib, Zanubrutinib, Tirabrutinib, and Pirtobrutinib have been clinically approved. All are covalent active site inhibitors, with the exception of the reversible active site inhibitor Pirtobrutinib. The large number of available inhibitors for the BTK target creates challenges in choosing the most appropriate BTKi for treatment. Side-by-side comparisons in CLL have shown that different inhibitors may differ in their treatment efficacy. Moreover, the nature of the resistance mutations that arise in patients appears to depend on the specific BTKi administered. We have previously shown that Ibrutinib binding to the kinase active site causes unanticipated long-range effects on the global conformation of BTK (Joseph et al., 2020). Here, we show that binding of each of the five approved BTKi to the kinase active site brings about distinct allosteric changes that alter the conformational equilibrium of full-length BTK. Additionally, we provide an explanation for the resistance mutation bias observed in CLL patients treated with different BTKi and characterize the mechanism of action of two common resistance mutations: BTK T474I and L528W.

    1. Biochemistry and Chemical Biology

    Target protein identification in live cells and organisms with a non-diffusive proximity tagging system

    Yingjie Sun, Changheng Li ... Youngnam N Jin
    Research Article

    Identifying target proteins for bioactive molecules is essential for understanding their mechanisms, developing improved derivatives, and minimizing off-target effects. Despite advances in target identification (target-ID) technologies, significant challenges remain, impeding drug development. Most target-ID methods use cell lysates, but maintaining an intact cellular context is vital for capturing specific drug–protein interactions, such as those with transient protein complexes and membrane-associated proteins. To address these limitations, we developed POST-IT (Pup-On-target for Small molecule Target Identification Technology), a non-diffusive proximity tagging system for live cells, orthogonal to the eukaryotic system. POST-IT utilizes an engineered fusion of proteasomal accessory factor A and HaloTag to transfer Pup to proximal proteins upon directly binding to the small molecule. After significant optimization to eliminate self-pupylation and polypupylation, minimize depupylation, and optimize chemical linkers, POST-IT successfully identified known targets and discovered a new binder, SEPHS2, for dasatinib, and VPS37C as a new target for hydroxychloroquine, enhancing our understanding these drugs’ mechanisms of action. Furthermore, we demonstrated the application of POST-IT in live zebrafish embryos, highlighting its potential for broad biological research and drug development.